Business Description
CStone Pharmaceuticals
ISIN : KYG2588M1006
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.83 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | -0.49 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -6.96 | |||||
Beneish M-Score | -1.61 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -30.1 | |||||
3-Year EBITDA Growth Rate | 42.7 | |||||
3-Year EPS without NRI Growth Rate | 30.2 | |||||
3-Year FCF Growth Rate | 4.8 | |||||
3-Year Book Growth Rate | -49.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.4 | |||||
9-Day RSI | 64.45 | |||||
14-Day RSI | 58.33 | |||||
6-1 Month Momentum % | -42.73 | |||||
12-1 Month Momentum % | -49.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.56 | |||||
Quick Ratio | 1.44 | |||||
Cash Ratio | 1.21 | |||||
Days Inventory | 108.77 | |||||
Days Sales Outstanding | 94.39 | |||||
Days Payable | 449.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.8 | |||||
Shareholder Yield % | -4.86 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.58 | |||||
Operating Margin % | -161.26 | |||||
Net Margin % | -156.83 | |||||
FCF Margin % | -41.85 | |||||
ROE % | -166.38 | |||||
ROA % | -45.68 | |||||
ROIC % | -97.52 | |||||
ROC (Joel Greenblatt) % | -411.87 | |||||
ROCE % | -98.83 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.81 | |||||
PB Ratio | 3.14 | |||||
Price-to-Tangible-Book | 4.67 | |||||
EV-to-EBIT | -0.93 | |||||
EV-to-EBITDA | -0.95 | |||||
EV-to-Revenue | 1.44 | |||||
EV-to-FCF | -3.5 | |||||
Price-to-Net-Current-Asset-Value | 14 | |||||
Earnings Yield (Greenblatt) % | -107.53 | |||||
FCF Yield % | -13.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CStone Pharmaceuticals Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 63.435 | ||
EPS (TTM) (€) | -0.084 | ||
Beta | -0.36 | ||
Volatility % | 66.04 | ||
14-Day RSI | 58.33 | ||
14-Day ATR (€) | 0.004224 | ||
20-Day SMA (€) | 0.1298 | ||
12-1 Month Momentum % | -49.75 | ||
52-Week Range (€) | 0.0945 - 0.3178 | ||
Shares Outstanding (Mil) | 1,275.32 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CStone Pharmaceuticals Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CStone Pharmaceuticals Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
CStone Pharmaceuticals Frequently Asked Questions
What is CStone Pharmaceuticals(STU:PH4)'s stock price today?
When is next earnings date of CStone Pharmaceuticals(STU:PH4)?
Does CStone Pharmaceuticals(STU:PH4) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |